Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Heparin Lyase
Managing patients with hematological malignancies during COVID-19 pandemic.
Rapid evaluation of gold nanoparticle-lipid membrane interactions using a lipid/polydiacetylene vesicle sensor.
Reversible "irreversible" inhibition of chymotrypsin using nanoparticle receptors.
Vesicular exanthema of swine virus
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Managing patients with hematological malignancies during COVID-19 pandemic.
Sahu KK, Cerny J. Managing patients with hematological malignancies during COVID-19 pandemic. Expert Rev Hematol. 2020 08; 13(8):787-793.
View in:
PubMed
subject areas
Betacoronavirus
Coronavirus Infections
Hematologic Neoplasms
Hematopoietic Stem Cell Transplantation
Humans
Leukemia
Pandemics
Pneumonia, Viral
Risk Factors
Severity of Illness Index
Survival Rate
authors with profiles
Jan Cerny MD, PhD